Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hyperlipoproteinemias

Known as: hyperlipoproteinaemias, Hyperlipoproteinemia, Hyperlipoproteinemias [Disease/Finding] 
Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary… Expand
National Institutes of Health

Related topics

Related topics

50 relations
24 HR fluvastatin 80 MG Extended Release Oral TabletAPOE geneAPOE wt AlleleAPOE*4 Allele
Expand

Narrower (4)

HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3Hyperlipoproteinemia Type ILipoprotein Types--Lp System Lp(A) Hyperlipoproteinemiafamilial hyperlipoproteinemia

Broader (1)

lipoprotein disorder

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
  • P. Libby
  • Circulation
  • 2001
    • Corpus ID: 2228001
The last decade has witnessed a major reassessment of our perceptions about the acute coronary syndromes. Today, we recognize… Expand
  • figure 1
  • figure 2
  • figure 3
Review
1999
Review
1999
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
The plasma clearance of intestinally derived remnant lipoproteins by the liver is a process that likely involves three steps. Our… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
1999
Review
1999
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
1988
Review
1988
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
Apolipoprotein E is a plasma protein that serves as a ligand for low density lipoprotein receptors and, through its interaction… Expand
Review
1988
Review
1988
Apolipoprotein E polymorphism and atherosclerosis.
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It… Expand
  • figure 1
  • table 1
  • table 3
  • figure 2
  • figure 3
Highly Cited
1979
Highly Cited
1979
Atherogenesis: a postprandial phenomenon.
The hypothesis that plasma chylomicrons in persons who ingest a cholesterol-rich diet are atherogenic is evaluated. Evidence is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
1974
Highly Cited
1974
Accelerated atherosclerosis in prolonged maintenance hemodialysis.
Abstract The survival experience of 39 patients receiving long-term regular hemodialysis in Seattle since 1960 was studied with… Expand
Highly Cited
1974
Highly Cited
1974
Platelet function in hyperlipoproteinemia.
Abstract Platelet function was studied in 17 patients with Type II hyperlipoproteinemia. As compared with 26 normal subjects… Expand
Highly Cited
1974
Highly Cited
1974
Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia
Analysis of cardiovascular status in adult relatives of 116 kindred affected with familial hyperbetalipoproteinemia (type II… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 2
Review
1970
Review
1970
Classification of hyperlipidaemias and hyperlipoproteinaemias.
Many studies of atherosclerosis have indicated hyperlipidaemia as a predisposing factor to vascular disease. The relationship… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE